Ngā hua rapu kaituhi

1

Personalized medicine in multiple sclerosis: hope or reality? mā Derfuss, Tobias

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis mā Diebold, Martin, Derfuss, Tobias

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Lymphocyte recovery after fingolimod discontinuation in patients with MS mā Nagy, Sara, Kuhle, Jens, Derfuss, Tobias

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

B Cells and Autoantibodies in Multiple Sclerosis mā Pröbstel, Anne-Katrin, Sanderson, Nicholas S. R., Derfuss, Tobias

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy mā Rust, Heiko, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Defining distinct features of anti-MOG antibody associated central nervous system demyelination mā Weber, Martin S., Derfuss, Tobias, Metz, Imke, Brück, Wolfgang

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

Relapse rates in patients with multiple sclerosis treated with fingolimod: subgroup analyses of pooled data from three phase 3 trials mā Derfuss, Tobias, Ontaneda, Daniel, Nicholas, Jacqueline, Meng, Xiangyi, Hawker, Kathleen

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation mā Voigt, David, Scheidt, Uta, Derfuss, Tobias, Brück, Wolfgang, Junker, Andreas

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis mā Waschbisch, Anne, Atiya, Monika, Linker, Ralf A., Potapov, Sergej, Schwab, Stefan, Derfuss, Tobias

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis mā Havla, Joachim, Warnke, Clemens, Derfuss, Tobias, Kappos, Ludwig, Hartung, Hans-Peter, Hohlfeld, Reinhard

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML mā Fischer-Barnicol, Bettina, Oechtering, Johanna, Kuhle, Jens, Lorscheider, Johannes, Kappos, Ludwig, Derfuss, Tobias

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Antiapoptotic Activity of the Herpesvirus Saimiri-Encoded Bcl-2 Homolog: Stabilization of Mitochondria and Inhibition of Caspase-3-Like Activity mā Derfuss, Tobias, Fickenscher, Helmut, Kraft, Michael S., Henning, Golo, Lengenfelder, Doris, Fleckenstein, Bernhard, Meinl, Edgar

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Prevalence of HSV‐1 LAT in Human Trigeminal, Geniculate, and Vestibular Ganglia and Its Implication for Cranial Nerve Syndromes mā Theil, Diethilde, Arbusow, Viktor, Derfuss, Tobias, Strupp, Michael, Pfeiffer, Matthias, Mascolo, Andrea, Brandt, Thomas

I whakaputaina 2006

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

Expression of Herpes Simplex Virus 1-Encoded MicroRNAs in Human Trigeminal Ganglia and Their Relation to Local T-Cell Infiltrates mā Held, Kathrin, Junker, Andreas, Dornmair, Klaus, Meinl, Edgar, Sinicina, Inga, Brandt, Thomas, Theil, Diethilde, Derfuss, Tobias

I whakaputaina 2011

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients mā Waschbisch, Anne, Sanderson, Nicholas, Krumbholz, Markus, Vlad, George, Theil, Diethilde, Schwab, Stefan, Mäurer, Mathias, Derfuss, Tobias

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment mā Diebold, Martin, Fischer-Barnicol, Bettina, Tsagkas, Charidimos, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias, Décard, Bernhard F.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis mā Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose mā Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Stangel, Martin, Zipp, Frauke

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Optimizing treatment success in multiple sclerosis mā Ziemssen, Tjalf, Derfuss, Tobias, de Stefano, Nicola, Giovannoni, Gavin, Palavra, Filipe, Tomic, Davorka, Vollmer, Tim, Schippling, Sven

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Aggressive multiple sclerosis (1): Towards a definition of the phenotype mā Iacobaeus, Ellen, Arrambide, Georgina, Amato, Maria Pia, Derfuss, Tobias, Vukusic, Sandra, Hemmer, Bernhard, Tintore, Mar, Brundin, Lou

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Derfuss, Tobias

Personalized medicine in multiple sclerosis: hope or reality? mā Derfuss, Tobias

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis mā Diebold, Martin, Derfuss, Tobias

Lymphocyte recovery after fingolimod discontinuation in patients with MS mā Nagy, Sara, Kuhle, Jens, Derfuss, Tobias

B Cells and Autoantibodies in Multiple Sclerosis mā Pröbstel, Anne-Katrin, Sanderson, Nicholas S. R., Derfuss, Tobias

Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy mā Rust, Heiko, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias

Defining distinct features of anti-MOG antibody associated central nervous system demyelination mā Weber, Martin S., Derfuss, Tobias, Metz, Imke, Brück, Wolfgang

Relapse rates in patients with multiple sclerosis treated with fingolimod: subgroup analyses of pooled data from three phase 3 trials mā Derfuss, Tobias, Ontaneda, Daniel, Nicholas, Jacqueline, Meng, Xiangyi, Hawker, Kathleen

Expression of the Antioxidative Enzyme Peroxiredoxin 2 in Multiple Sclerosis Lesions in Relation to Inflammation mā Voigt, David, Scheidt, Uta, Derfuss, Tobias, Brück, Wolfgang, Junker, Andreas

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis mā Waschbisch, Anne, Atiya, Monika, Linker, Ralf A., Potapov, Sergej, Schwab, Stefan, Derfuss, Tobias

Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis mā Havla, Joachim, Warnke, Clemens, Derfuss, Tobias, Kappos, Ludwig, Hartung, Hans-Peter, Hohlfeld, Reinhard

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML mā Fischer-Barnicol, Bettina, Oechtering, Johanna, Kuhle, Jens, Lorscheider, Johannes, Kappos, Ludwig, Derfuss, Tobias

Antiapoptotic Activity of the Herpesvirus Saimiri-Encoded Bcl-2 Homolog: Stabilization of Mitochondria and Inhibition of Caspase-3-Like Activity mā Derfuss, Tobias, Fickenscher, Helmut, Kraft, Michael S., Henning, Golo, Lengenfelder, Doris, Fleckenstein, Bernhard, Meinl, Edgar

Prevalence of HSV‐1 LAT in Human Trigeminal, Geniculate, and Vestibular Ganglia and Its Implication for Cranial Nerve Syndromes mā Theil, Diethilde, Arbusow, Viktor, Derfuss, Tobias, Strupp, Michael, Pfeiffer, Matthias, Mascolo, Andrea, Brandt, Thomas

Expression of Herpes Simplex Virus 1-Encoded MicroRNAs in Human Trigeminal Ganglia and Their Relation to Local T-Cell Infiltrates mā Held, Kathrin, Junker, Andreas, Dornmair, Klaus, Meinl, Edgar, Sinicina, Inga, Brandt, Thomas, Theil, Diethilde, Derfuss, Tobias

Interferon Beta and Vitamin D Synergize to Induce Immunoregulatory Receptors on Peripheral Blood Monocytes of Multiple Sclerosis Patients mā Waschbisch, Anne, Sanderson, Nicholas, Krumbholz, Markus, Vlad, George, Theil, Diethilde, Schwab, Stefan, Mäurer, Mathias, Derfuss, Tobias

Hepatitis E virus infections in patients with MS on oral disease-modifying treatment mā Diebold, Martin, Fischer-Barnicol, Bettina, Tsagkas, Charidimos, Kuhle, Jens, Kappos, Ludwig, Derfuss, Tobias, Décard, Bernhard F.

Comparative analysis of dimethyl fumarate and fingolimod in relapsing–remitting multiple sclerosis mā Lorscheider, Johannes, Benkert, Pascal, Lienert, Carmen, Hänni, Peter, Derfuss, Tobias, Kuhle, Jens, Kappos, Ludwig, Yaldizli, Özgür

Kommentar der Multiple Sklerose Therapie Konsensus Gruppe (MSTKG) zur S2k-Leitlinie Multiple Sklerose mā Wiendl, Heinz, Gold, Ralf, Berger, Thomas, Derfuss, Tobias, Linker, Ralf, Mäurer, Mathias, Stangel, Martin, Zipp, Frauke

Optimizing treatment success in multiple sclerosis mā Ziemssen, Tjalf, Derfuss, Tobias, de Stefano, Nicola, Giovannoni, Gavin, Palavra, Filipe, Tomic, Davorka, Vollmer, Tim, Schippling, Sven

Aggressive multiple sclerosis (1): Towards a definition of the phenotype mā Iacobaeus, Ellen, Arrambide, Georgina, Amato, Maria Pia, Derfuss, Tobias, Vukusic, Sandra, Hemmer, Bernhard, Tintore, Mar, Brundin, Lou

Ngā utauta rapu: